Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

Pharm World Sci. 2003 Aug;25(4):129-34. doi: 10.1023/a:1024819515862.

Abstract

In the UK, there has been a rapid increase in the reclassification of prescription only medicines (POMs) to pharmacy only (P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / economics
  • Antifungal Agents / therapeutic use*
  • Candidiasis, Vulvovaginal / diagnosis
  • Candidiasis, Vulvovaginal / drug therapy*
  • Clinical Trials as Topic
  • Community Pharmacy Services / standards
  • Evidence-Based Medicine
  • Female
  • Humans
  • Nonprescription Drugs / economics
  • Nonprescription Drugs / therapeutic use*
  • Quality Assurance, Health Care
  • Self Medication
  • United Kingdom

Substances

  • Antifungal Agents
  • Nonprescription Drugs